Literature DB >> 9188578

Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.

D Sa-Carvalho1, E Rieder, B Baxt, R Rodarte, A Tanuri, P W Mason.   

Abstract

Isolates of foot-and-mouth disease virus (FMDV) exist as complex mixtures of variants. Two different serotype O1 Campos preparations that we examined contained two variants with distinct plaque morphologies on BHK cells: a small, clear-plaque virus that replicates in BHK and CHO cells, and a large, turbid-plaque virus that only grows in BHK cells. cDNAs encoding the capsids of these two variants were inserted into a genome-length FMDV type A12 infectious cDNA and used to produce chimeric viruses that exhibited the phenotype of the original variants. Analyses of these viruses, and hybrids created by exchanging portions of the capsid gene, identified codon 56 in VP3 (3056) as the critical determinant of both cell tropism and plaque phenotype. Specifically, the CHO growth/clear-plaque phenotype is dependent on the presence of the highly charged Arg residue at 3056, and viruses with this phenotype and genotype were selected during propagation in tissue culture. The genetically engineered Arg 3056 virus was highly attenuated in bovines, but viruses recovered from animals inoculated with high doses of this virus had lost the ability to grow in CHO cells and contained either an uncharged residue at 3056 or a negatively charged Glu substituted for a Lys at a spatially and antigenically related position on VP2 (2134). Comparison of these animal-derived viruses to other natural and engineered viruses demonstrated that positively charged residues are required at both 2134 and 3056 for binding to heparin. Taken together, these results indicate that in vitro cultivation of FMDV type O selects viruses that bind to heparin and that viruses with the heparin-binding phenotype are attenuated in the natural host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188578      PMCID: PMC191746          DOI: 10.1128/JVI.71.7.5115-5123.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.

Authors:  J W Stave; J L Card; D O Morgan; V N Vakharia
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

2.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.

Authors:  R Acharya; E Fry; D Stuart; G Fox; D Rowlands; F Brown
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

3.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.

Authors:  D WuDunn; P G Spear
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.

Authors:  M G Mateu; M A Martínez; E Rocha; D Andreu; J Parejo; E Giralt; F Sobrino; E Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Host cell selection of antigenic variants of foot-and-mouth disease virus.

Authors:  C Bolwell; A L Brown; P V Barnett; R O Campbell; B E Clarke; N R Parry; E J Ouldridge; F Brown; D J Rowlands
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

6.  The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

Authors:  G Fox; N R Parry; P V Barnett; B McGinn; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

7.  The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification.

Authors:  K H Chang; P Auvinen; T Hyypiä; G Stanway
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

8.  Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.

Authors:  E Rieder; A Berinstein; B Baxt; A Kang; P W Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle.

Authors:  F Gebauer; J C de la Torre; I Gomes; M G Mateu; H Barahona; B Tiraboschi; I Bergmann; P A de Mello; E Domingo
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Analysis of neutralizing epitopes on foot-and-mouth disease virus.

Authors:  E Pfaff; H J Thiel; E Beck; K Strohmaier; H Schaller
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more
  129 in total

1.  Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus.

Authors:  H G van Rensburg; L H Nel
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.

Authors:  J Chinsangaram; M Koster; M J Grubman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo.

Authors:  C W Mandl; H Kroschewski; S L Allison; R Kofler; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis.

Authors:  Honey V Reddi; A S Manoj Kumar; Aisha Y Kung; Patricia D Kallio; Brian P Schlitt; Howard L Lipton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 6.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin.

Authors:  Jolanda M Smit; Barry-Lee Waarts; Koji Kimata; William B Klimstra; Robert Bittman; Jan Wilschut
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA.

Authors:  Eric Baranowski; Nicolás Molina; José Ignacio Núñez; Francisco Sobrino; Margarita Sáiz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.